UK markets open in 20 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,190.43 +427.40 (+2.41%) CRUDE OIL
79.53 +0.53 (+0.67%) GOLD FUTURES
2,326.00 +15.00 (+0.65%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,974.01 -1,640.05 (-3.44%)
Achilles Therapeutics plc (ACHL)
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 32.44M |
| Enterprise value | -94.48M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.23 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 1.34 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.09 |
| 52-week change 3 | -9.07% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 1.7600 |
| 52-week low 3 | 0.7400 |
| 50-day moving average 3 | 1.0845 |
| 200-day moving average 3 | 0.9492 |
Share statistics
| Avg vol (3-month) 3 | 730.6k |
| Avg vol (10-day) 3 | 228.58k |
| Shares outstanding 5 | 41.5M |
| Implied shares outstanding 6 | 41.5M |
| Float 8 | 21.21M |
| % held by insiders 1 | 6.71% |
| % held by institutions 1 | 50.89% |
| Shares short (15 Apr 2024) 4 | 37.83k |
| Short ratio (15 Apr 2024) 4 | 0.1 |
| Short % of float (15 Apr 2024) 4 | 0.15% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.09% |
| Shares short (prior month 15 Mar 2024) 4 | 68.9k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -24.61% |
| Return on equity (ttm) | -41.05% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -70.44M |
| Net income avi to common (ttm) | -69.67M |
| Diluted EPS (ttm) | -1.7400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 131.54M |
| Total cash per share (mrq) | 3.2 |
| Total debt (mrq) | 4.62M |
| Total debt/equity (mrq) | 3.24% |
| Current ratio (mrq) | 8.57 |
| Book value per share (mrq) | 3.46 |
Cash flow statement
| Operating cash flow (ttm) | -48.45M |
| Levered free cash flow (ttm) | -28.2M |
© 2024 Yahoo. All rights reserved.